Skip to content
The African Exponent DATA
Resources

Review pending. Every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review has not yet been carried out, and these pages are not indexed.AI-assisted source check done; independent review pending; not indexed. About the review

Tanganda Tea

TANG.ZW · Zimbabwe Stock Exchange · Company statements

On this page
Company details
Legal name
Tanganda Tea Company Limited
Listing
TANG.ZW on the Zimbabwe Stock Exchange, active · ISIN ZW0009012411 (observed 2026-10-08)
Sector
Not classified (our classification from the stated principal activity)
Financial year ends
30 September

Overview

Year ended 30 September 2025 · annual report, signed / final · source

  • Revenue

    USD 19.2 million

    19,178,383 USD units · p68

    Change not shown.

  • Operating profit / (loss)

    −USD 3.98 million

    (3,980,837) USD units · p68

    Change not shown.

  • Profit / (loss) for the year

    −USD 4.24 million

    (4,243,958) USD units · p68

    Change not shown.

  • Total assets

    USD 33.4 million

    33,362,995 USD units · p67

    Change not shown.

  • Total equity

    USD 19.0 million

    19,002,240 USD units · p67

    Change not shown.

  • Cash from operations

    USD 1.69 million

    1,685,695 USD units · p70

    Change not shown.

Large amounts are rounded for reading (USD million / billion / trillion); exact figures as printed are under each amount and in the tables. No currency conversion.

Not shown: the two years come from different filings.

Financial statements

Exact figures as printed. Each column comes from one filing; labels are as printed in the newest filing. Amounts in USD units unless the row says otherwise; brackets are negative.

† from a supplementary filing for the same year · ‡ signed audited statements preferred over a disputed figure · “–” is a printed dash, explained below the table

Column sources

  • FY to 30 Sep 2025 — annual report, signed / final; reported for the year · source
  • FY to 30 Sep 2024 — annual report, signed / final; reported for the year · source
  • FY to 30 Sep 2023 — annual report, signed / final; comparative in the FY to 30 Sep 2024 filing · source

Income statement

Income statement, USD units. Columns: FY to 30 Sep 2025 — annual report (signed / final), as reported for the year; FY to 30 Sep 2024 — annual report (signed / final), as reported for the year; FY to 30 Sep 2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY to 30 Sep 2025Annual reportreported for the yearFY to 30 Sep 2024Annual reportreported for the yearFY to 30 Sep 2023Annual reportcomparative in FY to 30 Sep 2024 filing
Revenue 19,178,383 25,766,340 23,595,458
Cost of sales (16,148,277) (16,974,532) (17,240,818)
Gross profit 3,030,106 8,791,808 6,354,640
Other expenses (4,006,649) (3,561,154) (4,313,412)
Selling and distribution expenses (3,513,277) (3,929,738) (3,886,079)
(Increase) / decrease in expected credit losses1 (62,151) 313,960 (445,117)
Other income 571,134 318,961 711,717
Operating (loss) / profit2 (3,980,837) 1,933,837 (1,578,251)
Net finance costs3 (1,049,216) (777,256) (931,358)
Equity accounted earnings 10,464 Not reported in this filing54 Not reported in this filing5
(Loss)/ profit before income tax6 (5,019,589) 1,156,581 (3,092,763)
Income tax credit7 775,631 209,142 (26,779)
(Loss)/ profit for the year8 (4,243,958) 1,365,723 (3,119,542)
Other comprehensive income –9 –9 –9
(Loss)/ profit for the year10 (4,243,958) 1,365,723 (3,119,542)
Monetary loss11 Not reported in this filing12 –13 (583,154)
  1. Printed “-”, read as nil: subtotal_arithmetic: is.total_comprehensive_income.
  2. Printed “-”, read as nil: subtotal_arithmetic: is.profit_before_tax.
Notes and alternative reported figures (11)
  1. Printed under different labels across filings: “(Increase) / decrease in expected credit losses”; “Decrease / (increase) in expected credit losses”.
  2. Printed under different labels across filings: “Operating (loss) / profit”; “Operating profit / (loss)”.
  3. “Net finance costs” is an issuer-specific line, not mapped to a shared definition: Note 24: interest expense less interest income.
  4. Annual report dated 2025-12-03 presents this line for this year: - (p68). Not shown in this column, which follows one filing's presentation.
  5. Not reported in this filing: Not reported: the FY2024 Statement of profit or loss and other comprehensive income (p64, text layer) prints no equity-accounted or share-of-associate line; below 'Operating profit / (loss)' it prints 'Net finance costs' and 'Monetary loss' only. 'Equity accounted earnings' first appears in the FY2025 statement (p68).
  6. Printed under different labels across filings: “(Loss)/ profit before income tax”; “Profit / (loss) before income tax”.
  7. Printed under different labels across filings: “Income tax credit”; “Income tax credit / (expense)”.
  8. Printed under different labels across filings: “(Loss)/ profit for the year”; “Profit / (loss) for the period”.
  9. Printed under different labels across filings: “(Loss)/ profit for the year”; “Total comprehensive income / (loss)”.
  10. “Monetary loss” is an issuer-specific line, not mapped to a shared definition: FY2024 report: loss on the net monetary position in the restated 2023 comparative (hyperinflation accounting before the change of functional currency to USD).
  11. Not reported in this filing: Not reported: the FY2025 Statement of profit or loss and other comprehensive income (p68, checked on the page image) prints no 'Monetary loss' line; below 'Operating (loss) / profit' it prints 'Net finance costs' and 'Equity accounted earnings'.

Balance sheet

Balance sheet, USD units. Columns: FY to 30 Sep 2025 — annual report (signed / final), as reported for the year; FY to 30 Sep 2024 — annual report (signed / final), as reported for the year; FY to 30 Sep 2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY to 30 Sep 2025Annual reportreported for the yearFY to 30 Sep 2024Annual reportreported for the yearFY to 30 Sep 2023Annual reportcomparative in FY to 30 Sep 2024 filing
Property, plant and equipment 19,934,735 20,034,801 20,283,842
Right of use assets 44,847 10,687 16,794
Biological assets1 1,603,387 1,645,154 1,163,106
Investment in Joint Venture 52,188 Not reported in this filing32 Not reported in this filing3
Non-current assets (subtotal) 21,635,157 21,690,642 21,463,742
Inventories 7,321,367 6,956,514 5,882,897
Produce on bearer plants4 116,645 112,173 220,106
Trade and other receivables 3,770,265 6,159,017 4,266,194
Bank and cash balances 519,561 224,613 152,249
Current assets (subtotal) 11,727,838 13,452,317 10,521,446
Total assets 33,362,995 35,142,959 31,985,188
Share capital 320,075 320,075 320,075
Share premium 7,675,801 7,675,801 7,675,801
Non-distributable reserve5 2,599,156 2,599,156 2,599,156
Retained earnings 8,407,208 12,651,166 11,285,443
Capital and reserves (subtotal) 19,002,240 23,246,198 21,880,475
Deferred tax 2,001,781 2,777,412 3,205,636
Lease liability 19,869 11,297 25,284
Long-term borrowings 4,076,176 2,937,639 1,267,716
Non-current liabilities (subtotal) 6,097,826 5,726,348 4,498,636
Trade and other payables 4,724,881 2,534,0786 4,277,939
Provisions 449,878 Not reported in this filing87 Not reported in this filing8
Lease liability 26,760 13,987 12,852
Current portion of long-term borrowings 2,431,744 3,093,792 1,216,981
Bank overdraft 629,666 498,041 93,373
Current tax liability –9 30,515 4,932
Current liabilities (subtotal) 8,262,929 6,170,413 5,606,077
Total liabilities 14,360,755 11,896,761 10,104,713
Total equity and liabilities 33,362,995 35,142,959 31,985,188
Intangible assets Not reported in this filing10 –11 –11
Other financial assets12 Not reported in this filing13 –11 –11
  1. Printed “-”, read as nil: subtotal_arithmetic: bs.current_liabilities.
  2. Printed “-”, read as nil: subtotal_arithmetic: bs.non_current_assets.
Notes and alternative reported figures (11)
  1. “Biological assets” is an issuer-specific line, not mapped to a shared definition: Note 10 (non-current).
  2. Annual report dated 2025-12-03 presents this line for this year: - (p67). Not shown in this column, which follows one filing's presentation.
  3. Not reported in this filing: Not reported: the FY2024 Statement of financial position (p65, text layer) prints no investment in joint venture or associate line; its non-current assets are 'Property, plant and equipment', 'Right of use assets', 'Intangible assets', 'Biological assets' and 'Other financial assets'.
  4. “Produce on bearer plants” is an issuer-specific line, not mapped to a shared definition: Note 12 (current).
  5. “Non-distributable reserve” is an issuer-specific line, not mapped to a shared definition: Note 15.4.
  6. Annual report dated 2025-12-03 prints 2 337 272 (units, p67) for this line and year.
  7. Annual report dated 2025-12-03 presents this line for this year: 196 806 (p67). Not shown in this column, which follows one filing's presentation.
  8. Not reported in this filing: Not reported: the FY2024 Statement of financial position (p65, text layer) prints no 'Provisions' line; its current liabilities are 'Trade and other payables', 'Lease liability', 'Current portion of long-term borrowings', 'Bank overdraft' and 'Current tax liability'. The FY2025 document presents 'Provisions' 196 806 for 2024 separately (p67), with 'Trade and other payables' 2 337 272 against 2 534 078 printed here; that comparative is a re-presentation not printed in this document.
  9. Not reported in this filing: Not reported: the FY2025 Statement of financial position (p67, text layer) prints no 'Intangible assets' line; its non-current assets are 'Property, plant and equipment', 'Right of use assets', 'Biological assets' and 'Investment in Joint Venture'.
  10. “Other financial assets” is an issuer-specific line, not mapped to a shared definition: Note 10 of the FY2024 report: non-current (nil at both 2024 and 2023 year ends).
  11. Not reported in this filing: Not reported: the FY2025 Statement of financial position (p67, text layer) prints no 'Other financial assets' line; its non-current assets are 'Property, plant and equipment', 'Right of use assets', 'Biological assets' and 'Investment in Joint Venture'.

Cash flow

Cash flow, USD units. Columns: FY to 30 Sep 2025 — annual report (signed / final), as reported for the year; FY to 30 Sep 2024 — annual report (signed / final), as reported for the year; FY to 30 Sep 2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY to 30 Sep 2025Annual reportreported for the yearFY to 30 Sep 2024Annual reportreported for the yearFY to 30 Sep 2023Annual reportcomparative in FY to 30 Sep 2024 filing
Cash generated from / (utilised in) operating activities1 1,685,695 (2,367,667)2 485,310
Purchase of property, plant and equipment (873,849) (682,693) (1,595,782)
Addition on biological assets34 (26,582) (3,024) (57,244)
Proceeds on disposal of property, plant and equipment 13,150 6,776 4,603
Investment in Joint venture5 (41,724) Not reported in this filing76 Not reported in this filing7
Interest received 292 282 1,032
Net cash utilised in investing activities (928,713) (678,659) (1,543,273)
Proceeds from borrowings 4,208,239 7,154,864 5,575,798
Repayment of borrowings (3,731,750) (3,608,129) (3,891,879)
Interest paid (1,041,738) (774,790) (928,761)
Lease payments (28,410) (15,600) (14,472)
Net cash (utilised in) / generated from financing activities8 (593,659) 2,756,345 557,562
Net decrease in cash and cash equivalents 163,323 (289,981)9 (500,401)
Cash and cash equivalents at the beginning of the year10 (273,428) 58,876 187,763
Cash and cash equivalents at the end of the year11 (110,105) (273,428) 58,876
Proceeds from disposal of biological assets12 Not reported in this filing13 –14 104,118
Dividend paid Not reported in this filing15 –16 (183,124)
Net effect of exchange rates on cash and cash equivalents Not reported in this filing17 (42,323) 371,514
  1. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_investing.
  2. Printed “-”, read as nil: subtotal_arithmetic: cf.cash_from_financing.
Notes and alternative reported figures (15)
  1. Printed under different labels across filings: “Cash (utilised in) / generated from operating activities”; “Cash generated from / (utilised in) operating activities”.
  2. Annual report dated 2025-12-03 prints (2 409 990) (units, p70) for this line and year.
  3. “Addition on biological assets” is an issuer-specific line, not mapped to a shared definition: Investing activities.
  4. Printed under different labels across filings: “Addition on biological assets”; “Expenditure on biological assets”.
  5. “Investment in Joint venture” is an issuer-specific line, not mapped to a shared definition: Investing activities (2025 only).
  6. Annual report dated 2025-12-03 presents this line for this year: - (p70). Not shown in this column, which follows one filing's presentation.
  7. Not reported in this filing: Not reported: the FY2024 Statement of cash flows (p67, text layer) prints no investment-in-joint-venture line; its investing lines are 'Purchase of property, plant and equipment', 'Expenditure on biological assets', 'Proceeds on disposal of property, plant and equipment', 'Proceeds from disposal of biological assets' and 'Interest received'.
  8. Printed under different labels across filings: “Net cash (utilised in) / generated from financing activities”; “Net cash generated from financing activities”.
  9. Annual report dated 2025-12-03 prints (332 304) (units, p70) for this line and year.
  10. Printed under different labels across filings: “Cash and cash equivalents at the beginning of the year”; “beginning of the period”.
  11. Printed under different labels across filings: “Cash and cash equivalents at the end of the period”; “Cash and cash equivalents at the end of the year”.
  12. “Proceeds from disposal of biological assets” is an issuer-specific line, not mapped to a shared definition: Investing activities (FY2024 report).
  13. Not reported in this filing: Not reported: the FY2025 Statement of cashflows (p70, text layer) prints no proceeds-from-disposal-of-biological-assets line; its investing lines are 'Purchase of property, plant and equipment', 'Addition on biological assets', 'Proceeds on disposal of property, plant and equipment', 'Investment in Joint venture' and 'Interest received'.
  14. Not reported in this filing: Not reported: the FY2025 Statement of cashflows (p70, text layer) prints no dividend line; its financing lines are 'Proceeds from borrowings', 'Repayment of borrowings', 'Interest paid' and 'Lease payments'.
  15. Not reported in this filing: Not reported: the FY2025 Statement of cashflows (p70, text layer) prints no exchange-rate effect line; it goes from 'Net decrease in cash and cash equivalents' 163 323 and 'Cash and cash equivalents at the beginning of the year' (273 428) to 'Cash and cash equivalents at the end of the year' (110 105).

Per share and shares

Per share and shares. Columns: FY to 30 Sep 2025 — annual report (signed / final), as reported for the year; FY to 30 Sep 2024 — annual report (signed / final), as reported for the year; FY to 30 Sep 2023 — annual report (signed / final), comparative reported in the annual report for 2024.
Line (as printed) FY to 30 Sep 2025Annual reportreported for the yearFY to 30 Sep 2024Annual reportreported for the yearFY to 30 Sep 2023Annual reportcomparative in FY to 30 Sep 2024 filing
Earnings / (loss) per share (per share)4 (0.0163)1 0.00522 (0.0119)3
  1. Printed as (1.63) cents; value converted to USD at 100 cents = 1 USD.
  2. Printed as 0.52 cents; value converted to USD at 100 cents = 1 USD.
  3. Printed as (1.19) cents; value converted to USD at 100 cents = 1 USD.
Notes and alternative reported figures (1)
  1. Earnings / (loss) per share: printed as “Basic”.

Segments

Segment data not yet collected for this company in the pilot.

Dividends

Proposed or recommended, declared and paid are different events and are kept apart. A statement that no dividend was proposed does not mean none was paid.

Dividend events, the issuer's wording, and amounts as printed
Year endedEventWording as printedAmountUnitSource
30 Sep 2024 Dividends paid (cash flow statement) Dividend paid 0printed “–”, read as nil USD units Annual report, p67
30 Sep 2023 Dividends paid (cash flow statement) Dividend paid (183,124) USD units Annual report, p67

Sources

Each filing used on this page, newest period first. Dates are the document's own; the date we retrieved a file is shown separately and is never a publication date.

  • Tanganda Tea Company Limited Annual Report 2025

    Year ended 30 September 2025 · Annual report · signed / final

    Audit: BDO Zimbabwe Chartered Accountants, unmodified opinion · signed

    Auditor's sign-off: BDO Zimbabwe, per Davison Madhigi CA(Z), Partner, Registered Public Auditor (PAAB 0610)

    Final status: Independent auditor's report of BDO Zimbabwe Chartered Accountants on the financial statements set out on pages 67 to 103, unmodified opinion (PDF p63), closed with a handwritten 'BDO Zimbabwe' signature above 'Per: Davison Madhigi CA(Z), Partner, Registered Public Auditor' (PAAB 0610), Harare, dated 03 December 2025 (PDF p66, page image). The statement of financial position states the statements were approved by the board and carries handwritten signatures of the Chairman (H. Nkala) and CEO (T.J.G. Fennell), each dated 3 December 2025 (PDF p67, page image).

    Document date
    3 Dec 2025
    Published
    17 Mar 2026
    Auditor's report
    3 Dec 2025
    Board approval
    3 Dec 2025
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 30 Sep 2025
    Basis
    company statements · USD units (printed “USD (column headings); note 2.2: rounded to the nearest dollar”)
    • The cash-flow statement's 'Cash and cash equivalents comprise' prints bank and cash balances of 519 661 for 2025, while the statement of financial position prints 519 561 (PDF pp67, 70, page images); 519 561 less the overdraft 629 666 gives the printed closing cash (110 105). The 'comprise' lines are not transcribed.
    • The cash-flow statement prints one operating line, which note 27 shows is after working-capital changes and tax paid; interest received is classified in investing and interest paid in financing activities; the net change line is labelled 'Net decrease' although 2025 is an increase of 163 323 (PDF p70).
    • The profit-or-loss statement repeats the label '(Loss)/ profit for the year' on the line after 'Other comprehensive income' (nil both years); that second line is recorded as total comprehensive income (PDF p68).
    Technical details
    File
    112 pages, with a text layer
    SHA-256
    831807dc64932f758cb94005b51e09a24e515a8085034c476314232a422e65ce
    Entity as printed
    Tanganda Tea Company Limited ('the Company')
    Exchange copy
    retrieved 2026-10-08T18:04:07Z

  • Tanganda Tea Company Limited Annual Report 2024

    Year ended 30 September 2024 · Annual report · signed / final

    Audit: Axcentium (Harare), unmodified opinion · signed

    Auditor's sign-off: Axcentium, per Lawrence Nyajeka, Partner (PAAB Practice Certificate Number 0598)

    Final status: Independent auditor's report of Axcentium on the financial statements set out on pages 64 to 102, unmodified opinion (PDF p62), closed with a handwritten 'Axcentium' signature above 'Axcentium, Per: Lawrence Nyajeka, Partner, PAAB Practice Certificate Number: 0598, Harare, Zimbabwe', dated 12 December 2024 (PDF p63, page image). The statement of financial position states the statements on pages 64 to 102 were approved by the Board and carries handwritten signatures of the Chairman (H. Nkala) and CEO (T.J.G. Fennell), each dated 11 December 2024 (PDF p65, page image).

    Document date
    12 Dec 2024
    Published
    20 Feb 2025
    Auditor's report
    12 Dec 2024
    Board approval
    11 Dec 2024
    Retrieved by us
    8 Oct 2026 (not a publication date)
    Used for
    statement columns FY to 30 Sep 2024, FY to 30 Sep 2023
    Basis
    company statements · USD units (printed “USD (column headings)”)
    • The cash-flow statement prints one operating line (note 28); interest received is classified in investing and interest paid in financing activities (PDF p67). The statement of financial position prints a third column, 1 October 2022 (restated), not transcribed (PDF p65).
    • All comparative columns are headed 'Restated' with the footnote '*Prior year amounts reported in ZWL now reported in USD, refer to note 2.3 on change in functional currency and note 28.1 for prior year profit or loss and other comprehensive income restatement' (PDF pp64, 65, 67). The 2023 comparatives are therefore not the amounts of the FY2023 report as published (ZWL).
    Technical details
    File
    110 pages, with a text layer
    SHA-256
    5878f4f9fb2fd05ce2f3f873100addc98cd38711ead14eb239dbecf5bf226476
    Entity as printed
    Tanganda Tea Company Limited ('the Company')
    Exchange copy
    retrieved 2026-10-08T18:05:09Z

Data notes

No figure-level notes beyond those in the tables.

Review status: every figure has been located on its cited source page in an AI-assisted source verification (matched to the document's text) (17 October 2026). Independent review is pending for every figure; automated checks and the AI-assisted verification are not independent review.

Download

Figures shown on this page (CSV) — the same selected figures at their exact printed values, each with its source document, SHA-256, page, selection rule and reading. Independent review of these figures is pending.

· Company methodology and coverage